Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions

被引:158
作者
Atkins, WM [1 ]
机构
[1] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
关键词
allosterism; drug metabolism; enzyme kinetics; CYP;
D O I
10.1146/annurev.pharmtox.45.120403.100004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cytochrome P450 monooxygenases (CYPs) are the dominant enzyme system responsible for xenobiotic detoxification and drug metabolism. Several CYP isoforms exhibit non-Michaelis-Menten, or "atypical," steady state kinetic patterns. The allosteric kinetics confound prediction of drug metabolism and drug-drug interactions, and they challenge the theoretical paradigms of allosterism. Both homotropic and heterotropic ligand effects are now widely documented. It is becoming apparent that multiple ligands can simultaneously bind within the active sites of individual CYPs, and the kinetic parameters change with ligand occupancy. In fact, the functional effect of any specific ligand as an activator or inhibitor can be substrate dependent. Divergent approaches, including kinetic modeling and X-ray crystallography, are providing new information about how multiple ligand binding yields complex CYP kinetics.
引用
收藏
页码:291 / 310
页数:20
相关论文
共 99 条
[1]  
ACKERS GK, 1998, SCIENCE, V305, P185
[2]   METABOLIC SWITCHING IN CYTOCHROME-P-450CAM - DEUTERIUM-ISOTOPE EFFECTS ON REGIOSPECIFICITY AND THE MONOOXYGENASE OXIDASE RATIO [J].
ATKINS, WM ;
SLIGAR, SG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (12) :3754-3760
[3]   Allosteric behavior in cytochrome P450-dependent in vitro drug-drug interactions: A prospective based on conformational dynamics [J].
Atkins, WM ;
Wang, RW ;
Lu, AYH .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (04) :338-347
[4]   Is there a toxicological advantage for non-hyperbolic kinetics in cytochrome P450 catalysis? Functional allostery from "distributrve catalysis" [J].
Atkins, WM ;
Lu, WYD ;
Cook, DL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (36) :33258-33266
[5]   CYTOCHROME-P450 AND AROMATIC BASES - A H-1-NMR STUDY [J].
BANCI, L ;
BERTINI, I ;
MARCONI, S ;
PIERATTELLI, R ;
SLIGAR, SG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (11) :4866-4873
[6]  
Beechem J. M., 2002, TOPICS FLUORESCENCE, P241, DOI DOI 10.1007/0-306-47058-6_5
[7]   CYTOCHROME-P450 - PROGRESS AND PREDICTIONS [J].
COON, MJ ;
DING, XX ;
PERNECKY, SJ ;
VAZ, ADN .
FASEB JOURNAL, 1992, 6 (02) :669-673
[8]   Engineering microsomal cytochrome P4502C5 to be a soluble, monomeric enzyme - Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding [J].
Cosme, J ;
Johnson, EF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2545-2553
[9]   Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity [J].
Cupp-Vickery, J ;
Anderson, R ;
Hatziris, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3050-3055
[10]   Pyrene-pyrene complexes at the active site of cytochrome P450 3A4: Evidence for a multiple substrate binding site [J].
Dabrowski, MJ ;
Schrag, ML ;
Wienkers, LC ;
Atkins, WM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (40) :11866-11867